Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates

Harmony Biosciences (HRMY) Tops Q4 EPS by 16c, Revenues Beat

March 25, 2021 8:01 AM EDT

Harmony Biosciences (NASDAQ: HRMY) reported Q4 EPS of $0.25, $0.16 better than the analyst estimate of $0.09. Revenue for the quarter came in at $56.3 million versus the consensus estimate of $51.85 million.

Harmony achieved many milestones during 2020 and has entered 2021 well positioned to advance our strategic objectives, stated John C. Jacobs, President and Chief Executive... More